Ironwood Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | 24.6% | 24.6% | — |
| FY2010 | -32.5% | -32.5% | -17.2% |
| FY2011 | -59.0% | -59.0% | -31.0% |
| FY2012 | -50.4% | -50.4% | -31.6% |
| FY2013 | -713.7% | -713.7% | -97.8% |
| FY2014 | -214.1% | -214.1% | -57.6% |
| FY2015 | -150.0% | -45.2% | -23.0% |
| FY2016 | -122.5% | -122.5% | -11.5% |
| FY2017 | -1,187.4% | -1,187.4% | -19.3% |
| FY2018 | 143.8% | 143.8% | -85.0% |
| FY2019 | -23.1% | -23.1% | 5.3% |
| FY2020 | 169.5% | 21.5% | 19.0% |
| FY2021 | 87.2% | 49.8% | 46.9% |
| FY2022 | 26.8% | 16.7% | 15.9% |
| FY2023 | 289.4% | 289.4% | -212.8% |
| FY2024 | -0.3% | -0.3% | 0.3% |
| FY2025 | -9.2% | -9.2% | 6.1% |